GlassScriptPhysician profile
William W Kerfoot
NPI 1104886001
$1,271.64
in general payments reported to CMS, 2019-2025
12 companies · $59.89 in 2025
The $59.89 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,052 · 2020: $86.22 · 2021: $13.33 · 2022: $15.53 · 2023: $45.11 · 2025: $59.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $105.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $535.98 | 2019 | |
| Rochester Medical Corporation | $182.31 | 2019-2020 | |
| Abbvie INC. | $149.47 | 2019-2025 | |
| Astellas Pharma US INC | $143.00 | 2019 | |
| Janssen Biotech, INC. | $55.57 | 2019-2021 | |
| Antares Pharma, INC. | $44.09 | 2019 | |
| Blue Earth Diagnostics | $35.88 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $33.61 | 2019 | |
| Pfizer INC. | $29.24 | 2019 | |
| Coloplast Corp | $24.77 | 2019 | |
| Amgen INC. | $18.86 | 2019 | |
| Merck Sharp & Dohme LLC | $18.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Kerfoot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.